| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |